Lisa Stockdale
MPH, PhD
Senior Immunologist
Pre-erythrocytic Malaria Clinical Trials
Senior Immunologist
Pre-erythrocytic Malaria Clinical Trials
As the Senior immunologist in the pre-erythrocytic malaria vaccine group, I coordinate the clinical immunology of all R21/Matrix-M vaccine trials. These include trials studying vaccine immunogenicity in populations with co-morbidities, different age groups, and using alternative dosing regimens.
Having spent 5 years in Industry working in small molecule drug development, I completed a Master of International Public Health at York University, and a PhD in Tuberculosis Vaccine Immunology at London School of Hygiene and Tropical Medicine, before joining the Oxford Vaccine Group as a post-doc where I conducted research on Typhoid conjugate vaccine immunology and Covid-19 vaccine development and immunology.
I joined the Pre-erythrocytic Malaria group at the Jenner Institute in 2021. My research interests include correlates of vaccine-induced protection, investigation of mediators of antibody function, immunological interactions between different pathogens and sero-epidemiology.
I am an Early Career Researcher representative for the Medical Sciences Division and the Nuffield Department of Medicine and a lead of the Jenner Research Staff Network.
Recent publications
-
A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's disease.
Journal article
Sanderson J. et al, (2025), EBioMedicine, 113
-
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials.
Journal article
Venkatraman N. et al, (2025), Lancet Microbe, 6
-
R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study.
Journal article
Venkatraman N. et al, (2025), Lancet Microbe, 6
-
The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01E.
Journal article
Ali MS. et al, (2025), NPJ Vaccines, 10
-
Validation of a multiplexed immunoassay for immunological analysis of pre erythrocytic malaria vaccines.
Journal article
Stockdale LK. et al, (2025), NPJ Vaccines, 10